Biopharma Daily Stock Updates - 02/10/21

$XBI $168.01 -2% 📉

PIPELINE:

$PLX -11% Phase 3 data from BRIDGE trial of pegunigalsidase alfa (PRX–102) treating Fabry Disease. source

$VNDA +9% Reported Q4 20 sales and pipeline updates. source

FINANCIAL:

$SAVA -14% Offering

$ACET +22% Prices offering $13/sh

$TVTX -4% Offering

TMXD -15% Offering

$KDMN -7% Offering